| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2105777 | Biology of Blood and Marrow Transplantation | 2008 | 12 Pages |
Abstract
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role and timing of allogeneic and autologous transplantation in AML are poorly defined. This review critically analyzes the extensive literature, focusing on the recent advances, and provides practical recommendations for the use of HSCT in AML.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mehdi Hamadani, Farrukh T. Awan, Edward A. Copelan,